Companies / C4 Therapeutics, Inc. / Activity
Activity — C4 Therapeutics, Inc.
32 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 14, 2026 | Hirsch Andrew CEO | Other | Common Stock | $74.0K | -39K -3.49% | 1,083,991 0.88% of shares | low |
| Feb 14, 2026 | Reyno Leonard Executive | Other | Common Stock | $31.3K | -17K -4.18% | 379,803 0.31% of shares | low |
| Feb 14, 2026 | Adams Kendra Executive | Other | Common Stock | $29.1K | -15K -3.84% | 385,098 0.31% of shares | low |
| Jan 16, 2026 | Reyno Leonard Executive | Sell | Common Stock | $22.2K | -10K -6.01% | 156,382 0.13% of shares | low |
| Feb 15, 2026 | Hirsch Andrew CEO | Other | Common Stock | $17.1K | -9K -0.84% | 1,074,934 0.87% of shares | low |
| Jan 2, 2026 | Grogan Donna Roy Director | Grant | Common Stock | $14.5K | +8K +12.81% | 66,142 0.05% of shares | low |
| Feb 14, 2026 | Schick Kelly Executive | Other | Common Stock | $13.7K | -7K -2.37% | 299,881 0.24% of shares | low |
| Feb 14, 2026 | Boyle Scott N Executive | Other | Common Stock | $13.7K | -7K -2.37% | 298,801 0.24% of shares | low |
| Jan 2, 2026 | Anderson Kenneth Carl Director | Grant | Common Stock | $11.5K | +6K +4.24% | 146,532 0.12% of shares | low |
| Feb 14, 2026 | Mossler Mark Executive | Other | Common Stock | $6.2K | -3K -4.35% | 71,916 0.06% of shares | low |
| Feb 14, 2026 | Mahaney Paige Executive | Other | Common Stock | $4.6K | -2K -0.72% | 336,910 0.27% of shares | low |
| Feb 13, 2026 | Adams Kendra Executive | Other | Common Stock | $3.5K | -2K -0.46% | 400,479 0.33% of shares | low |
| Feb 13, 2026 | Schick Kelly Executive | Other | Common Stock | $3.3K | -2K -0.56% | 307,150 0.25% of shares | low |
| Feb 13, 2026 | Boyle Scott N Executive | Other | Common Stock | $3.3K | -2K -0.56% | 306,070 0.25% of shares | low |
| Feb 14, 2026 | Schick Kelly Executive | Exercise | Common Stock | $0 | +21K +7.32% | 307,150 0.25% of shares | low |
| Feb 13, 2026 | Schick Kelly Executive | Exercise | Common Stock | $0 | +5K +1.65% | 308,885 0.25% of shares | low |
| Feb 13, 2026 | Schick Kelly Executive | Grant | Common Stock | $0 | +200K +183.68% | 308,885 0.25% of shares | low |
| Feb 14, 2026 | Boyle Scott N Executive | Exercise | Common Stock | $0 | +21K +7.35% | 306,070 0.25% of shares | low |
| Feb 13, 2026 | Boyle Scott N Executive | Exercise | Common Stock | $0 | +5K +1.65% | 307,805 0.25% of shares | low |
| Feb 13, 2026 | Boyle Scott N Executive | Grant | Common Stock | $0 | +200K +185.52% | 307,805 0.25% of shares | low |
| Feb 14, 2026 | Mahaney Paige Executive | Exercise | Common Stock | $0 | +7K +2.12% | 339,356 0.28% of shares | low |
| Feb 13, 2026 | Mahaney Paige Executive | Grant | Common Stock | $0 | +240K +241.56% | 339,356 0.28% of shares | low |
| Feb 15, 2026 | Hirsch Andrew CEO | Exercise | Common Stock | $0 | +20K +1.92% | 1,083,991 0.88% of shares | low |
| Feb 14, 2026 | Hirsch Andrew CEO | Exercise | Common Stock | $0 | +82K +7.85% | 1,123,145 0.91% of shares | low |
| Feb 13, 2026 | Hirsch Andrew CEO | Grant | Common Stock | $0 | +700K +165.43% | 1,123,145 0.91% of shares | low |
| Feb 14, 2026 | Reyno Leonard Executive | Exercise | Common Stock | $0 | +31K +8.47% | 396,382 0.32% of shares | low |
| Feb 13, 2026 | Reyno Leonard Executive | Grant | Common Stock | $0 | +240K +153.47% | 396,382 0.32% of shares | low |
| Feb 14, 2026 | Adams Kendra Executive | Exercise | Common Stock | $0 | +31K +8.38% | 400,479 0.33% of shares | low |
| Feb 13, 2026 | Adams Kendra Executive | Exercise | Common Stock | $0 | +4K +0.94% | 402,342 0.33% of shares | low |
| Feb 13, 2026 | Adams Kendra Executive | Grant | Common Stock | $0 | +240K +147.84% | 402,342 0.33% of shares | low |
| Feb 14, 2026 | Mossler Mark Executive | Exercise | Common Stock | $0 | +9K +14.32% | 75,184 0.06% of shares | low |
| Feb 13, 2026 | Mossler Mark Executive | Grant | Common Stock | $0 | +57K +313.01% | 75,184 0.06% of shares | low |